The Relationship Between Characteristics of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Hospitalized with Blood Eosinophil Levels at Waled Regional Hospital in September 2023-September 2024
DOI:
https://doi.org/10.51601/ijhp.v6i2.594Abstract
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder with persistent airflow limitation and prone to acute exacerbations, in which blood eosinophil levels have been proposed as a marker of type 2 inflammation and response to therapy. This study aimed to determine the relationship between clinical-demographic characteristics of patients with acute exacerbations of COPD hospitalized at Waled Regional Hospital and blood eosinophil levels during the period of September 2023–September 2024. This study was a quantitative observational analytical study with a cross-sectional design conducted on 132 inpatients with exacerbations of COPD who met the inclusion criteria based on medical records, including diagnosis, first-time blood eosinophil laboratory results, and the absence of active helminth infections. Data were collected retrospectively from medical records and analyzed using univariate descriptive statistics and Spearman's rank correlation test in SPSS. The results showed that 62.1% of patients were male, 68.9% were aged ≥60 years, 75.0% had normal eosinophils (0–300 cells/μL), and 25.0% had elevated eosinophils (>300 cells/μL). Statistical tests found a significant but weak association between male gender and blood eosinophil levels (p = 0.023, rs = 0.198), while no significant association was found between age or occupational history and eosinophil levels. The results showed that in this regional referral hospital setting, elevated eosinophils were more common in male patients with acute exacerbation of COPD, while age and occupation did not show a significant association. The conclusions of the study underscore the need for larger prospective studies to clarify the role of eosinophils as a marker of severity and response to therapy in low-middle-income areas.
Downloads
References
[1] Albanna, A., Almuyidi, FM, Beitar, NF, Alshumrani, AS, Al Nufaiei, ZF, & Khayat, R. (2022). Clinical charac-teristics and outcomes related to blood eosinophilic chronic obstructive pulmonary disease (COPD) patients. Cu-reus, 14(1), e21045. https://doi.org/10.7759/cureus.21045
[2] Antariksa, B., Bahtiar, A., & Wiyono, WH (2023). Guidelines for the diagnosis and management of COPD (Chronic Obstructive Pulmonary Disease). Indonesian Pulmonary Physician Association.
[3] Agarwal, A.K., Raja, A., & Brown, B. (2024). Chronic obstructive pulmonary disease. In StatPearls. StatPearls Publishing.https://www.ncbi.nlm.nih.gov/books/NBK559281/
[4] Chattopadhyay, B. P. (2023). Blood eosinophil levels and ventilatory pulmonary function among workers ex-posed to grain dust. Indian Journal of Occupational and Environmental Medicine, 27(2), 134–140.
[5] Chipps, B.E., Jarjour, N., Calhoun, W.J., Iqbal, A., Haselkorn, T., & Yang, M. (2021). Stability of blood eosino-phil levels in patients with respiratory disease. Annals of the American Thoracic Society, 18(12), 1978–1987. https://doi.org/10.1513/AnnalsATS.202101-015OC
[6] Creswell, J. W., & Creswell, J. D. (2022). Research design: Qualitative, quantitative, and mixed methods ap-proaches (6th ed.). SAGE Publications.
[7] Creswell, J. W. (2023). Educational research: Planning, conducting, and evaluating quantitative and qualitative research (6th ed.). Pearson.
[8] Cui, Y., Zhang, W., Ma, Y., Zhan, Z., & Chen, Y. (2021). Stability of blood eosinophils in acute exacerbation of COPD and its relationship to clinical outcomes. Respiratory Research, 22(1), 1–10. https://doi.org/10.1186/s12931-021-01656-2
[9] Emzir. (2023). Educational research methodology: Quantitative and qualitative. Rajawali Press.
[10] Fahyim, SMM, Abdel Halim, HA, & Hassan, ESSM (2024). Blood eosinophil variability in COPD exacerbations and correlation with treatment plans. Egyptian Journal of Bronchology, 18(1), 1–9.
[11] Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2023). Global strategy for the diagnosis, man-agement, and prevention of COPD.https://www.goldcopd.org
[12] Hartl, S., Breyer, M.K., Burghuber, O.C., Ofenheimer, A., Schrott, A., & Urban, M.H. (2020). Blood eosinophil count in the general population: Typical values and confounders. European Respiratory Journal, 55(5), 1901874. https://doi.org/10.1183/13993003.01874-2019
[13] Ikawati, Z. (2022). Epidemiology of chronic obstructive pulmonary disease in Indonesia. Indonesian Journal of Respirology, 42(1), 12–20.
[14] Johnson, B., & Christensen, L. (2023). Educational research: Quantitative, qualitative, and mixed approaches (7th ed.). SAGE Publications.
[15] Juthong, S., & Kaenmuang, P. (2020). Association between blood eosinophils and COPD exacerbation in para-sitic endemic areas. Journal of Thoracic Disease, 12(9), 4868–4876.
[16] Kang, HS, Kim, SK, Kim, YH, Kim, JW, Lee, SH, & Yoon, HK (2021). Association between eosinophilic exac-erbation and eosinophil levels in COPD. BMC Pulmonary Medicine, 21(1), 1–9.
[17] Ministry of Health of the Republic of Indonesia. (2018). National report of Riskesdas 2018.
[18] Ministry of Health of the Republic of Indonesia. (2019). National guidelines for medical services for the man-agement of COPD.
[19] Ministry of Health of the Republic of Indonesia. (2023). Guidelines for medical record-based health research.
[20] Liu, S., Zhou, Y., Liu, S., Chen, X., Zou, W., Zhao, D., & Li, X. (2021). Association between occupational ex-posure and COPD risk. International Journal of Chronic Obstructive Pulmonary Disease, 16, 123–134.
[21] Lommatzsch, M., Nair, P., & Virchow, J. C. (2024). Normal blood eosinophil counts in humans. Respiration, 103(4), 214–216.
[22] MacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B.R., & Wedzicha, J.A. (2021). COPD exacerbation fun-damentals. Respirology, 26(6), 532–551.
[23] Nair, P., et al. (2023). Eosinophils in COPD and airway inflammation. Journal of Allergy and Clinical Immu-nology, 151(2), 345–356.
[24] Narayanasamy, N., & Josyula, L. (2024). Occupational exposure to air pollutants and COPD risk in construction workers: A meta-analysis. Indian Journal of Occupational and Environmental Medicine, 28(4), 313–318.
[25] Indonesian Pulmonary Physicians Association. (2021). Guidelines for the diagnosis and management of COPD.
[26] Ritchie, A.I., & Wedzicha, J.A. (2020). Definition and causes of COPD exacerbations. Clinics in Chest Medicine, 41(3), 421–438.
[27] Singh, D. (2020). Blood eosinophils as a biomarker in COPD. Tuberculosis and Respiratory Diseases, 83(3), 185–194.
[28] Singh, D., Agusti, A., Martinez, F.J., Papi, A., Pavord, I.D., & Wedzicha, J.A. (2022). Blood eosinophils and COPD. American Journal of Respiratory and Critical Care Medicine, 206(1), 17–24.
[29] Sitanggang, FT, Sakdiah, S., Simanjuntak, JP, Mustopa, R., & Yuliandari, N. (2022). Eosinophils and IgE as biomarkers in COPD. Indonesian Scientific Journal, 7(7), 1–12.
[30] Sugiyono. (2022). Quantitative, qualitative, and R&D research methods. Alfabeta.
[31] Sundar, K. M. (2023). Eosinophilia. In StatPearls. StatPearls Publishing.
[32] World Health Organization. (2022). Chronic obstructive pulmonary disease (COPD).https://www.who.int
[33] Yang, M., Yang, T., Li, X., Li, D., Liao, Z., & Shen, Y. (2021). Clinical predictors of high blood eosinophils in COPD. International Journal of COPD, 16, 2467–2474.
[34] Yang, M., Lv, Y., Tang, S., Xu, D., Li, D., & Liao, Z. (2024). Blood eosinophil count determinants in population-based cohorts. Respiration, 103(2), 70–78.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jidni Alaya Suryadirezi, Dwi Rosa Eka Agustina, Isti Noviani
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
